Literature DB >> 29029253

Breathing Disturbances Without Hypoxia Are Associated With Objective Sleepiness in Sleep Apnea.

Henriette Koch1,2,3, Logan Douglas Schneider1, Laurel A Finn4, Eileen B Leary1, Paul E Peppard4, Erika Hagen4, Helge Bjarup Dissing Sorensen2, Poul Jennum3, Emmanuel Mignot1.   

Abstract

Study
Objectives: To determine whether defining two subtypes of sleep-disordered breathing (SDB) events-with or without hypoxia-results in measures that are more strongly associated with hypertension and sleepiness.
Methods: A total of 1022 participants with 2112 nocturnal polysomnograms from the Wisconsin Sleep Cohort were analyzed with our automated algorithm, developed to detect breathing disturbances and desaturations. Breathing events were time-locked to desaturations, resulting in two indices-desaturating (hypoxia-breathing disturbance index [H-BDI]) and nondesaturating (nonhypoxia-breathing disturbance index [NH-BDI]) events-regardless of arousals. Measures of subjective (Epworth Sleepiness Scale) and objective (2981 multiple sleep latency tests from a subset of 865 participants) sleepiness were analyzed, in addition to clinically relevant clinicodemographic variables. Hypertension was defined as BP ≥ 140/90 or antihypertensive use.
Results: H-BDI, but not NH-BDI, correlated strongly with SDB severity indices that included hypoxia (r ≥ 0.89, p ≤ .001 with 3% oxygen-desaturation index [ODI] and apnea hypopnea index with 4% desaturations). A doubling of desaturation-associated events was associated with hypertension prevalence, which was significant for ODI but not H-BDI (3% ODI OR = 1.06, 95% CI = 1.00-1.12, p < .05; H-BDI OR 1.04, 95% CI = 0.98-1.10) and daytime sleepiness (β = 0.20 Epworth Sleepiness Scale [ESS] score, p < .0001; β = -0.20 minutes in MSL on multiple sleep latency test [MSLT], p < .01). Independently, nondesaturating event doubling was associated with more objective sleepiness (β = -0.52 minutes in MSL on MSLT, p < .001), but had less association with subjective sleepiness (β = 0.12 ESS score, p = .10). In longitudinal analyses, baseline nondesaturating events were associated with worsening of H-BDI over a 4-year follow-up, suggesting evolution in severity. Conclusions: In SDB, nondesaturating events are independently associated with objective daytime sleepiness, beyond the effect of desaturating events. © Sleep Research Society 2017. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Outcome Assessment (Health Care); Pattern recognition; automated; sleep apnea syndromes

Mesh:

Year:  2017        PMID: 29029253      PMCID: PMC6251661          DOI: 10.1093/sleep/zsx152

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  53 in total

Review 1.  Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS).

Authors:  Heather M Engleman; Matt R Wild
Journal:  Sleep Med Rev       Date:  2003-02       Impact factor: 11.609

2.  Snoring (I). Daytime sleepiness in regular heavy snorers.

Authors:  C Guilleminault; R Stoohs; S Duncan
Journal:  Chest       Date:  1991-01       Impact factor: 9.410

3.  Screening for Improvement of Health Outcomes in Asymptomatic Obstructive Sleep Apnea.

Authors:  Gregory S Carter
Journal:  JAMA Neurol       Date:  2017-04-01       Impact factor: 18.302

4.  The Circadian System Contributes to Apnea Lengthening across the Night in Obstructive Sleep Apnea.

Authors:  Matthew P Butler; Carolina Smales; Huijuan Wu; Mohammad V Hussain; Yusef A Mohamed; Miki Morimoto; Steven A Shea
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

5.  Multiple naps and the evaluation of daytime sleepiness in patients with upper airway sleep apnea.

Authors:  T Roth; K M Hartse; F Zorick; W Conway
Journal:  Sleep       Date:  1980       Impact factor: 5.849

6.  Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnoea syndrome.

Authors:  C Guilleminault; Y Do Kim; S Chowdhuri; M Horita; M Ohayon; C Kushida
Journal:  Eur Respir J       Date:  2001-05       Impact factor: 16.671

7.  Upper airway pressure-flow relationships in obstructive sleep apnea.

Authors:  P L Smith; R A Wise; A R Gold; A R Schwartz; S Permutt
Journal:  J Appl Physiol (1985)       Date:  1988-02

8.  Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning.

Authors:  Terri E Weaver; Greg Maislin; David F Dinges; Thomas Bloxham; Charles F P George; Harly Greenberg; Gihan Kader; Mark Mahowald; Joel Younger; Allan I Pack
Journal:  Sleep       Date:  2007-06       Impact factor: 5.849

9.  Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.

Authors:  Danny J Eckert; David P White; Amy S Jordan; Atul Malhotra; Andrew Wellman
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

10.  Self-evaluated and close relative-evaluated Epworth Sleepiness Scale vs. multiple sleep latency test in patients with obstructive sleep apnea.

Authors:  Yun Li; Jihui Zhang; Fei Lei; Hong Liu; Zhe Li; Xiangdong Tang
Journal:  J Clin Sleep Med       Date:  2014-02-15       Impact factor: 4.062

View more
  18 in total

1.  Why a Single Index to Measure Sleep Apnea Is Not Enough.

Authors:  Vishesh K Kapur; Lucas M Donovan
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

2.  Hypopnea Scoring Criteria: Time to Move Toward a Single Standardized Definition.

Authors:  Mukesh Kapoor
Journal:  J Clin Sleep Med       Date:  2018-11-15       Impact factor: 4.062

3.  Proteomic biomarkers of sleep apnea.

Authors:  Aditya Ambati; Yo-El Ju; Ling Lin; Alexander N Olesen; Henriette Koch; Julien Jacques Hedou; Eileen B Leary; Vicente Peris Sempere; Emmanuel Mignot; Shahrad Taheri
Journal:  Sleep       Date:  2020-11-12       Impact factor: 5.849

4.  To Die, to Sleep - to Sleep, Perchance to Dream…Without Hypertension: Dreams of the Visionary Christian Guilleminault Revisited.

Authors:  Shahrokh Javaheri; Peter C Gay
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

Review 5.  Phenotypic Subtypes of OSA: A Challenge and Opportunity for Precision Medicine.

Authors:  Andrey Zinchuk; Henry K Yaggi
Journal:  Chest       Date:  2019-09-17       Impact factor: 9.410

6.  Incidence of hypertension in obstructive sleep apnea using hypopneas defined by 3 percent oxygen desaturation or arousal but not by only 4 percent oxygen desaturation.

Authors:  Rohit Budhiraja; Sogol Javaheri; Sairam Parthasarathy; Richard B Berry; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

7.  Severity of Desaturations Reflects OSA-Related Daytime Sleepiness Better Than AHI.

Authors:  Samu Kainulainen; Juha Töyräs; Arie Oksenberg; Henri Korkalainen; Sandra Sefa; Antti Kulkas; Timo Leppänen
Journal:  J Clin Sleep Med       Date:  2019-08-15       Impact factor: 4.062

8.  Polysomnographic analysis of respiratory events during sleep in young nonobese Japanese adults without clinical complaints of sleep apnea.

Authors:  Mutsumi Okura; Shigeru Nonoue; Akiko Tsujisaka; Shingo Haraki; Chizuko Yokoe; Masako Taniike; Takafumi Kato
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

Review 9.  Reinventing polysomnography in the age of precision medicine.

Authors:  Diane C Lim; Diego R Mazzotti; Kate Sutherland; Jesse W Mindel; Jinyoung Kim; Peter A Cistulli; Ulysses J Magalang; Allan I Pack; Philip de Chazal; Thomas Penzel
Journal:  Sleep Med Rev       Date:  2020-03-20       Impact factor: 11.609

10.  Polysomnography for Obstructive Sleep Apnea Should Include Arousal-Based Scoring: An American Academy of Sleep Medicine Position Statement.

Authors:  Raman K Malhotra; Douglas B Kirsch; David A Kristo; Eric J Olson; Rashmi N Aurora; Kelly A Carden; Ronald D Chervin; Jennifer L Martin; Kannan Ramar; Carol L Rosen; James A Rowley; Ilene M Rosen
Journal:  J Clin Sleep Med       Date:  2018-07-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.